TRα protects against atherosclerosis in male mice: Identification of a novel anti-inflammatory property for TRα in mice

Endocrinology

Volumn 155, Issue 7, 2014, Pages 2735-2745

  Billon, Cyrielle ^a   Canaple, Laurence ^a   Fleury, Sébastien ^b   Deloire, Alexandre ^a   Beylot, Michel ^c   Dombrowicz, David ^b   Del Carmine, Peggy ^c   Samarut, Jacques ^a   Gauthier, Karine ^a  

^a UNIVERSITÉ DE LYON   (France)

^b UNIV LILLE   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PROTEIN KINASE B; THYROID HORMONE RECEPTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DRUG IDENTIFICATION; ENZYME ACTIVATION; ENZYME INHIBITION; LIPID STORAGE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN BLOOD LEVEL;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOTTING, WESTERN; BONE MARROW TRANSPLANTATION; CELL NUCLEUS; CELLS, CULTURED; CHOLESTEROL; INFLAMMATION; INTERLEUKIN-1BETA; MACROPHAGES; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID HORMONE RECEPTORS ALPHA; THYROID HORMONES;

EID: 84903288850     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1098     Document Type: Article

References (43)

1. Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell. 2001;104:503-516.
2. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473(7347):317-325.
3. Ghosh S, Zhao B, Bie J, Song J. Macrophage cholesteryl ester mobilization and atherosclerosis. Vascul Pharmacol. 2010;52(1-2):1-10.
4. Yvan-Charvet L, Pagler T, Gautier E, et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science. 2010;328(5986):1689-1693.
5. Yvan-Charvet L, Wang N, Tall AR. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol. 2010;30(2):139-143.
6. Kirii H, Niwa T, Yamada Y, et al. Lack of interleukin-1 β decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2003;23(4):656-660. (Pubitemid 36438080)
7. Elhage R, Maret A, Pieraggi MT, Thiers JC, Arnal JF, Bayard F. Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice. Circulation. 1998;97(3):242-244. (Pubitemid 28067308)
8. Dinarello C. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;(27):519-550.
9. Chen LF, Greene WC. Shaping the nuclear action of NF-κB. Nat Rev Mol Cell Biol. 2004;5(5):492-401.
10. Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab. 2003;88(6):2438-2444. (Pubitemid 36724408)
11. Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(12):1365-1374.
12. Singh S, Duggal J, Molnar J, Maldonado F, Barsano CP, Arora R. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int J Cardiol. 2008;125(1):41-48. (Pubitemid 351305426)
13. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000;132(4):270-278. (Pubitemid 30106257)
14. Baxter JD, Webb P. Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat Rev Drug Discov. 2009;8(4):308-320.
15. Flamant F, Gauthier K, Samarut J. Thyroid hormones signaling is getting more complex: STORMs are coming. Mol Endocrinol. 2007;21(2):321-333. (Pubitemid 46184888)
16. Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev. 2010;31(2):139-170.
17. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell. 2006;126(4):789-799. (Pubitemid 44233630)
18. Gullberg H, Rudling M, Saltó C, Forrest D, Angelin B, Vennström B. Requirement for thyroid hormone receptor β in T3 regulation of cholesterol metabolism in mice. Mol Endocrinol. 2002;16(8):1767-1777. (Pubitemid 34828087)
19. Grover GJ, Mellström K, Ye L, et al. Selective thyroid hormone receptor-β activation: a strategy for reduction of weight, cholesterol, and lipoprotein(a) with reduced cardiovascular liability. Proc Natl Acad Sci USA. 2003;100(17):10067-10072. (Pubitemid 37098262)
20. Tancevski I, Rudling M, Eller P. Thyromimetics: a journey from bench to bed-side. Pharmacol Ther. 2011;131(1):33-39.
21. Mai W, Janier MF, Allioli N, et al. Thyroid hormone receptor α is a molecular switch of cardiac function between fetal and postnatal life. Proc Natl Acad Sci USA. 2004;101(28):10332-10337. (Pubitemid 38924925)
22. Gauthier K, Plateroti M, Harvey CB, et al. Genetic analysis reveals different functions for the products of the thyroid hormone receptor α locus. Mol Cell Biol. 2001;21(14):4748-4760. (Pubitemid 32588255)
23. Jornayvaz, FR, Lee HY, Jurczak MJ, et al. Thyroid hormone receptor-α gene knockout mice are protected from diet-induced hepatic insulin resistance. Endocrinology. 2012;153(2):583-591.
24. Pelletier P, Gauthier K, Sideleva O, Samarut J, Silva JE. Mice lacking the thyroid hormone receptor-alpha gene spend more energy in thermogenesis, burn more fat, and are less sensitive to high-fat dietinduced obesity. Endocrinology. 2008;149(12):6471-6486.
25. Contreras-Jurado C, García-Serrano L, Gómez-Ferrería M, Costa C, Paramio JM, Aranda A. The thyroid hormone receptors as modulators of skin proliferation and inflammation. J Biol Chem. 2011;286(27):24079-24088.
26. Perrotta C, Buldorini M, Assi E, et al. The thyroid hormone triiodothyronine controls macrophage maturation and functions: protective role during inflammation. Am J Pathol. 2014;184(1):230-247.
27. Selmi-Ruby S, Bouazza L, Obregon MJ, et al. The Targeted inactivation of TRβ gene in thyroid follicular cells suggests a new mechanism of regulation of thyroid hormone production. Endocrinology. 2014;155(2):635-646.
28. Kellendonk C, Opherk C, Anlag K, Schütz G, Tronche F. Hepatocyte-specific expression of Cre recombinase. Genesis. 2000;26:151-153. (Pubitemid 30158105)
29. Weiss RE, Murata Y, Cua K, Hayashi Y, Seo H, Refetoff S. Thyroid hormone action on liver, heart, and energy expenditure in thyroid hormone receptor β-deficient mice. Endocrinology. 1998;139(12):4945-4952. Erratum in: Endocrinology. 2000;141(12):4767. (Pubitemid 28533441)
30. Nakaya K, Ayaori M, Hisada T, et al. Telmisartan enhances cholesterol efflux from THP-1 macrophages by activating PPARγ. J Atheroscler Thromb. 2007;14(3):133-141.
31. Gauthier K, Billon C, Bissler M, et al. Thyroid hormone receptor β (TRβ) and liver X receptor (LXR) regulate carbohydrate-response element-binding protein (ChREBP) expression in a tissue-selective manner. J Biol Chem. 2010;285(36):28156-28163.
32. Macchia PE, Takeuchi Y, Kawai T, et al. Increased sensitivity to thyroid hormone in mice with complete deficiency of thyroid hormone receptor α. Proc Natl Acad Sci USA. 2001;98(1):349-354. (Pubitemid 32095912)
33. Kress E, Rezza A, Nadjar J, Samarut J, Plateroti M. The thyroid hormone receptor-α (TRα) gene encoding TRα1 controls deoxyribonucleic acid damage-induced tissue repair. Mol Endocrinol. 2008;22(1):47-55.
34. -/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am J Pathol. 2006;168(2):649-658.
35. Ait-Oufella H, Taleb S, Mallat Z, Tedgui A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol. 2011;31(5):969-979.
36. Verga Falzacappa C, Petrucci E, Patriarca V, et al. Thyroid hormone receptor TRβ1 mediates Akt activation by T3 in pancreatic β cells. J Mol Endocrinol. 2007;38(1-2):221-233. (Pubitemid 46351605)
37. Temel RE, Brown JM. Biliary and non-biliary contributions to reverse cholesterol transport. Curr Opin Lipidol. 2012;23(2):85-90.
38. Lin JZ, Martagón AJ, Hsueh WH, et al. Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor. Endocrinology. 2012;153(12):6136-6144.
39. Goldberg IJ, Huang LS, Huggins LA, et al. Thyroid hormone reduces cholesterol via a non-LDL receptor-mediated pathway. Endocrinology. 2012;153(11):5143-5149.
40. Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov. 2012;11(8):633-652.
41. Persson J, Nilsson J, Lindholm M. Interleukin-1β and tumour necrosis factor-α impede neutral lipid turnover in macrophage-derived foam cells. BMC Immunol. 2008;9:70.
42. McLaren JE, Michael DR, Ashlin TG, Ramji DP. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy. Prog Lipid Res. 2011;50(4):331-347.
43. Kronqvist R, Leppimäki P, Mehto P, Slotte J. The effect of interleukin 1 β on the biosynthesis of cholesterol, phosphatidylcholine, and sphingomyelin in fibroblasts, and on their efflux from cells to lipid-free apolipoprotein A-I. Eur J Biochem. 1999;262(3):939-946. (Pubitemid 29291055)